Addressing ethical challenges in HIV prevention research with people who inject drugs

Despite recent advances in HIV prevention and treatment, high HIV incidence persists among people who inject drugs (PWID). Difficult legal and political environments and lack of services for PWID likely contribute to high HIV incidence. Some advocates question whether any HIV prevention research is...

Full description

Saved in:  
Bibliographic Details
Authors: Dawson, Liza (Author) ; Strathdee, A. (Author) ; London, Alex John (Author) ; Lancaster, E. (Author) ; Klitzman, Robert (Author) ; Hoffman, Irving (Author) ; Rose, Scott (Author) ; Sugarman, Jeremy (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Published: 2018
In: Journal of medical ethics
Year: 2018, Volume: 44, Issue: 3, Pages: 149-158
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002c 4500
001 1816157414
003 DE-627
005 20230428063454.0
007 cr uuu---uuuuu
008 220908s2018 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2015-102895  |2 doi 
035 |a (DE-627)1816157414 
035 |a (DE-599)KXP1816157414 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Dawson, Liza  |e VerfasserIn  |4 aut 
245 1 0 |a Addressing ethical challenges in HIV prevention research with people who inject drugs 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Despite recent advances in HIV prevention and treatment, high HIV incidence persists among people who inject drugs (PWID). Difficult legal and political environments and lack of services for PWID likely contribute to high HIV incidence. Some advocates question whether any HIV prevention research is ethically justified in settings where healthcare system fails to provide basic services to PWID and where implementation of research findings is fraught with political barriers. Ethical challenges in research with PWID include concern about whether research evidence will be translated into practice; concerns that research might exacerbate background risks; and ethical challenges regarding the standard of HIV prevention in research. While these questions arise in other research settings, for research with PWID, these questions are especially controversial. This paper analyses four ethical questions in determining whether research could be ethically acceptable: (1) Can researchers ensure that research does not add to the burden of social harms and poor health experienced by PWID? (2) Should research be conducted in settings where it is uncertain whether research findings will be translated into practice? (3) When best practices in prevention and care are not locally available, what standard of care and prevention is ethically appropriate? (4) Does the conduct of research in settings with oppressive policies constitute complicity? We outline specific criteria to address these four ethical challenges. We also urge researchers to join the call to action for policy change to provide proven safe and effective HIV prevention and harm reduction interventions for PWID around the world. 
601 |a Challenger 
700 1 |a Strathdee, A.  |e VerfasserIn  |4 aut 
700 1 |a London, Alex John  |e VerfasserIn  |4 aut 
700 1 |a Lancaster, E.  |e VerfasserIn  |4 aut 
700 1 |a Klitzman, Robert  |e VerfasserIn  |4 aut 
700 1 |a Hoffman, Irving  |e VerfasserIn  |4 aut 
700 1 |a Rose, Scott  |e VerfasserIn  |4 aut 
700 1 |a Sugarman, Jeremy  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 44(2018), 3, Seite 149-158  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnas 
773 1 8 |g volume:44  |g year:2018  |g number:3  |g pages:149-158 
856 |3 Volltext  |u http://www.jstor.org/stable/26879684  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/44/3/149.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [deprecated] 
856 4 0 |u https://doi.org/10.1136/medethics-2015-102895  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/44/3/149.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185611358 
LOK |0 003 DE-627 
LOK |0 004 1816157414 
LOK |0 005 20220908053718 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#F8537823C2555B2AE3E1B775D3CB2F6F62E5A904 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/26879684 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw